Streamlined FDA Process Could Aid Biotech Device Makers

A budding crop of Central Ohio biotech firms likely will welcome changes starting this month in the federal approval process for low-risk medical devices.  The US Food and Drug Administration this year released a 25-point plan to be implemented over the course of 2011 to simplify and make more consistent the review of applications for new devices. 

For more details of the changes, as well as its potential impact on local medical device developers, see the story in Business First.